NCT05449626|Completed
Loading search results
Sponsor study identifier
observational
400
1 country
1
Study Start
July 26, 2022
Actual (reported)Primary Completion
October 6, 2022
Actual (reported)Study Completion
January 6, 2023
Actual (reported)The aim of our study is to verify the validity and reliability of the Turkish version of B-GYA.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 6, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 4, 2022
Actual (reported)July 8, 2022
Actual (reported)July 26, 2022
Actual (reported)October 6, 2022
Actual (reported)January 6, 2023
Actual (reported)Standardized Mini Mental Test
For the first time, Folstein et al. \[12\] and found to be valid and reliable in the diagnosis of mild dementia in the Turkish population will be used. SMMT, which measures mental state, is a scale that evaluates cognitive functions in five separate sections (orientation, registration, attention and calculation, recall and language). The test can be easily applied in daily medical practice and is very suitable for screening cognitive function in the elderly. The total score is 30. The cut-off point of the scale was determined as 24.
Up to 6 months
Clinical Dementia Rating Scale
The Clinical Dementia Rating Scale was developed by Woolf in 2016 in order to have information about the participant's memory, orientation, judgment and problem-solving ability, functionality outside the home, home life, hobbies and personal care. An evaluation will be made by asking detailed questions about all the areas specified in this test, which will be applied to the patient and their relatives. According to the answers given in each field, it will be scored as 0-0.5-1-2-3 by using the score table in the front of the test. It is a general assessment made to determine the dementia stage of the person. 0.5-1 mild, 1-2 moderate, 2-3 advanced stages of dementia.
Up to 6 months
The Standardized Mini-Mental Test and Clinical Dementia Rating Scale will be administered by the physician to the healthy individuals with dementia to be included in the study.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
200 individuals and healthy individuals who were diagnosed with Alzheimer's according to the international diagnostic criteria of the American National Neurological and Communication Disorders Stroke and Alzheimer Association (NINCDS-ADRDA) and were in mild and moderate stages (\<2) according to the Clinical Dementia Rating: CDR. 200 individuals found will be included
Yeditepe University
Istanbul, Turkiye, Turkey (Türkiye)
400 participants (actual enrollment reported by the registry).
First Submitted
July 4, 2022
First Posted
July 8, 2022
Study Start
July 26, 2022
Actual (reported)Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy
Reliability And Validity Of The Usage Of The Camry Dynamometer In Healthy Adults
Contact the study team to confirm eligibility.
Primary Completion
October 6, 2022
Actual (reported)Study Completion
January 6, 2023
Actual (reported)Last Updated
July 3, 2023
Record last verified: 2023-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: